Middle East Pharmaceutical Industries Co.
Last Updated:
- 119.50 SAR
- -0.10
- -0.08%
شركة الشرق الأوسط للصناعات الدوائية
أفالون فارما
Symbol :
4016
ISIN :
SA160G51UO10
52-Week Range :
107.00
-
144.60
Turnover Ratio :
0.91
Market :
Saudi Exchange
Sector :
Pharma, Biotech & Life Science
Industry :
Health Care Supplies
Sub-Industry :
Basic Information
-
Activity :
-
Industry Group :Health care supplies & services
-
Sub-Industry :
-
ISIN :SA160G51UO10
-
Contact Person :--
-
Established On:--
-
Stock Listing On :--
-
No of Employees :--
-
Outstanding Shares :--
-
Free Float Shares :
-
Par Value :
-
Paid Capital :
-
Market Cap :
Indices Membership
Data Not Available
Management
Data Not Available
Reports
| Date | Title | File |
|---|---|---|
| 2025 | AVALON PHARMA Quarterly Financials Report Q1 2025 | |
| 2025 | AVALON PHARMA Annual Financials Report 2024 | |
| 2025 | Avalon Pharma Earnings Release Financial Year 24 | |
| 2024 | AVALON PHARMA Quarterly Financials Report Q3 2024 | |
| 2024 | AVALON PHARMA Quarterly Financials Report Q2 2024 | |
| 2024 | AVALON PHARMA Quarterly Financials Report Q1 2024 | |
| 2024 | Avalon delivers strong start to 2024 with a remarkable 37% increase in revenue, high profitability and substantial rise in net profit | |
| 2024 | AVALON PHARMA Annual Financials Report 2023 | |
| 2024 | Middle East Pharmaceutical Industries Company(“Avalon Pharma”) Announces the Final Offer Price | |
| 2024 | Middle East Pharmaceutical Industries Company(“Avalon Pharma”) Announces its IPO Offer Price Range and Commencement of Institutional Book Building | |
| 2024 | Middle East Pharmaceutical Industries Company (“Avalon Pharma”) Announces its Intention to Float on the Saudi Exchange’s Main Market |
